What the Vote Means for Patients and Clinicians It may create a future regulated access route The practical promise of the vote is a possible patient-specific pharmacy pathway
mimics insomnia, fatigue, headaches, and mood changes Depression and anxiety disorders primary mood disorders can present with menopause-like somatic symptoms Diabetes and insulin resistance can cause fatigue, weight gain, and night sweats Medication side effects niacin, some antidepressants, tamoxifen, aromatase inhibitors, opioids, steroids, and some osteoporosis or diabetes medications can cause flushing or sweating Primary ovarian insufficiency menopause-like symptoms before 40 should be specifically evaluated Less common causes carcinoid tumors, pheochromocytoma, autoimmune disease A clinician should rule these in or out particularly when a symptom is severe, atypical, or not improving with appropriate treatment
"FDA Approves First Medication for Obstructive Sleep Apnea." Zepbound (tirzepatide) approved for moderate-to-severe OSA in adults with obesity
The cells in our body use Adenosine triphosphate but we'll just call it ATP as a source of energy, and creatine helps to provide energy within the muscles too
Two days after the first intramuscular B12 injection, the patient developed an acneiform eruption on her glabella, nose, cheeks, and perioral area
S9A-D ) and semaglutide at a dose previously shown to attenuate alcohol-related behaviors (25) ( Fig